Atherton Lane Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $625K | Sell |
7,417
-38
| -0.5% | -$3.2K | 0.04% | 133 |
|
|
2015
Q3 | $624K | Sell |
7,455
-50
| -0.7% | -$4.19K | 0.04% | 134 |
|
|
2015
Q2 | $627K | Sell |
7,505
-74
| -1% | -$6.18K | 0.03% | 134 |
|
|
2015
Q1 | $551K | Sell |
7,579
-985
| -12% | -$71.6K | 0.03% | 163 |
|
|
2014
Q4 | $591K | Buy |
8,564
+16
| +0.2% | +$1.1K | 0.03% | 161 |
|
|
2014
Q3 | $554K | Sell |
8,548
-235
| -3% | -$15.2K | 0.03% | 173 |
|
|
2014
Q2 | $546K | Sell |
8,783
-1,032
| -11% | -$64.2K | 0.03% | 176 |
|
|
2014
Q1 | $578K | Sell |
9,815
-19,390
| -66% | -$1.14M | 0.04% | 98 |
|
|
2013
Q4 | $1.49M | Sell |
29,205
-387,631
| -93% | -$19.8M | 0.09% | 79 |
|
|
2013
Q3 | $21M | Buy |
416,836
+1,365
| +0.3% | +$68.7K | 1.44% | 29 |
|
|
2013
Q2 | $20.4M | Buy |
+415,471
| New | +$20.4M | 1.49% | 24 |
|